{"title":"Rational Tuning of Intracellular Release Kinetics in PROTAC–Peptide Conjugates via Positional Modulation of Functional Peptide Domains","authors":"Maho Miyamoto, Atsuki Hirama, Kosuke Saito, Naoki Shida, Mahito Atobe, Hidetomo Yokoo, Yosuke Demizu","doi":"10.1021/acsbiomedchemau.6c00158","DOIUrl":null,"url":null,"abstract":"<p>Proteolysis-targeting\r\nchimeras (PROTACs) can induce degradation\r\nof otherwise challenging proteins, but their large size and unfavorable\r\nphysicochemical properties often limit cellular delivery. We designed\r\nPROTAC–peptide conjugates containing a nona-arginine cell-penetrating\r\npeptide (<strong>R9</strong>), a redox-sensitive disulfide linker, and\r\nan aromatic-rich peptide sequence previously described as an endosomal\r\nescape domain (EED). The EED sequence was positioned at either the\r\nN- or C-terminus to examine how peptide-domain arrangement affects\r\nintracellular fluorescence, payload release, and BRD4 degradation.\r\nAt 10 and 100 nM, the C-terminal variant <strong>MZ1-R9-EED</strong> produced\r\na greater reduction in BRD4 abundance at 24 h than <strong>MZ1-R9</strong> and <strong>MZ1-EED-R9</strong>, although the two-concentration comparison\r\ndid not permit determination of DC<sub>50</sub>, <em>D</em><sub>max</sub>, or hook effects. FAM-based flow cytometry yielded\r\npH-sensitive cell-associated fluorescence signals that could not be\r\ninterpreted as an absolute measure of total cellular uptake. Qualitative\r\nconfocal microscopy showed punctate fluorescence with apparent LysoTracker\r\noverlap but did not provide quantitative evidence of endosomal escape.\r\nUnder a defined cell-free reducing condition, <strong>MZ1-R9-EED</strong> underwent faster apparent disulfide cleavage, with a half-life of\r\n0.21 h versus 0.36–0.47 h for the other conjugates, and yielded\r\nhigher apparent intracellular free <strong>MZ1</strong> levels under identical\r\nanalytical conditions. Square-wave voltammetry revealed no substantial\r\ndifferences in reduction potential, whereas molecular dynamics simulations\r\nsuggested a possible contribution of local steric accessibility. These\r\nfindings associate peptide-domain positioning with cleavage kinetics,\r\nfree-payload levels, and BRD4 reduction, identifying domain arrangement\r\nas a design variable for disulfide-linked PROTAC–peptide conjugates\r\nwithout establishing cleavage as the rate-limiting or causal mechanism.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"6 5","pages":"744–751"},"PeriodicalIF":3.5000,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.6c00158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Proteolysis-targeting
chimeras (PROTACs) can induce degradation
of otherwise challenging proteins, but their large size and unfavorable
physicochemical properties often limit cellular delivery. We designed
PROTAC–peptide conjugates containing a nona-arginine cell-penetrating
peptide (R9), a redox-sensitive disulfide linker, and
an aromatic-rich peptide sequence previously described as an endosomal
escape domain (EED). The EED sequence was positioned at either the
N- or C-terminus to examine how peptide-domain arrangement affects
intracellular fluorescence, payload release, and BRD4 degradation.
At 10 and 100 nM, the C-terminal variant MZ1-R9-EED produced
a greater reduction in BRD4 abundance at 24 h than MZ1-R9 and MZ1-EED-R9, although the two-concentration comparison
did not permit determination of DC50, Dmax, or hook effects. FAM-based flow cytometry yielded
pH-sensitive cell-associated fluorescence signals that could not be
interpreted as an absolute measure of total cellular uptake. Qualitative
confocal microscopy showed punctate fluorescence with apparent LysoTracker
overlap but did not provide quantitative evidence of endosomal escape.
Under a defined cell-free reducing condition, MZ1-R9-EED underwent faster apparent disulfide cleavage, with a half-life of
0.21 h versus 0.36–0.47 h for the other conjugates, and yielded
higher apparent intracellular free MZ1 levels under identical
analytical conditions. Square-wave voltammetry revealed no substantial
differences in reduction potential, whereas molecular dynamics simulations
suggested a possible contribution of local steric accessibility. These
findings associate peptide-domain positioning with cleavage kinetics,
free-payload levels, and BRD4 reduction, identifying domain arrangement
as a design variable for disulfide-linked PROTAC–peptide conjugates
without establishing cleavage as the rate-limiting or causal mechanism.
期刊介绍:
ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.